Format

Send to

Choose Destination
Am J Respir Crit Care Med. 2011 Oct 15;184(8):972-9. doi: 10.1164/rccm.201105-0827WS.

CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap.

Author information

1
Division of Pulmonary and Critical Care, Curry International Tuberculosis Center, San Francisco General Hospital, University of California-San Francisco, CA 94110, USA. pnahid@ucsf.edu

Abstract

The Centers for Disease Control and Prevention and National Institutes of Health convened a multidisciplinary meeting to discuss surrogate markers of treatment response in tuberculosis. The goals were to assess recent surrogate marker research and to provide specific recommendations for (1) the qualification and validation of biomarkers of treatment outcome; (2) the standardization of specimen and data collection for future clinical trials, including a minimum set of samples and collection time points; and (3) the creation ofa specimen repository to support biomarker testing. This article summarizes these recommendations and provides a roadmap for their implementation.

PMID:
21737585
PMCID:
PMC3208659
DOI:
10.1164/rccm.201105-0827WS
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center